tyrosine has been researched along with Liver Dysfunction in 111 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 64 (57.66) | 18.7374 |
1990's | 19 (17.12) | 18.2507 |
2000's | 15 (13.51) | 29.6817 |
2010's | 10 (9.01) | 24.3611 |
2020's | 3 (2.70) | 2.80 |
Authors | Studies |
---|---|
Abdelgawad, MA; El-Mesery, M; Gomaa, HAM; Hazem, SH; Shaaban, AA; Shaker, ME | 1 |
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
Abe, M; Adachi, T; Aibiki, T; Hiasa, Y; Hiraoka, A; Hirooka, M; Iwasaki, R; Kato, M; Kuroda, T; Marui, K; Matsuoka, J; Matsuura, B; Michitaka, K; Miyata, H; Murakami, T; Ninomiya, T; Okudaira, T; Onishi, K; Suga, Y; Tsuruta, M; Ueki, H; Yoshino, T | 1 |
Alvarez, F; Mitchell, GA | 1 |
Aktuglu-Zeybek, AC; Cansever, MS; Kiykim, E | 1 |
Inoue, J; Iwata, T; Kakazu, E; Kogure, T; Morosawa, T; Nakamura, T; Ninomiya, M; Sano, A; Shimosegawa, T; Takai, S; Umetsu, T | 1 |
Berry, GT; Brucker, WJ; Demirbas, D | 1 |
Cho, JY; Chung, JY; Jang, IJ; Ji, SC; Kim, DJ; Kim, YK; Lee, S; Yang, J; Yoon, S; Yu, KS | 1 |
Kuo, HC; Lee, KF; Tsai, JJ; Tsai, TH | 1 |
Chiu, WC; Chiu, YS; Hou, YC; Li, CC; Yang, HT | 1 |
Dalekos, GN; Kaffe, ET; Koukoulis, GK; Moulas, AN; Rigopoulou, EI | 1 |
Bekpinar, S; Gurdol, F; Unlucerci, Y; Uysal, M | 1 |
Bland, KI; Chaudry, IH; Choudhry, MA; Hsu, JT; Kan, WH; Raju, R; Schwacha, MG | 1 |
Chen, H; Li, Y; Yu, YN | 1 |
Fernández-Checa, JC; García-Ruiz, C; Llacuna, L; Lluis, JM; Marí, M; Morales, A | 1 |
Lehnert, M; Lemasters, JJ; Lind, H; Marzi, I; Schoonhoven, R; Zhong, Z | 1 |
SHLIMOVITZ, N; WARTMAN, WB | 1 |
Borque, MJ; Gamallo, C; García-Buey, L; García-Sánchez, A; Jones, EA; Martín-Vílchez, S; Medina, J; Moreno-Otero, R; Sanz-Cameno, P | 1 |
Habib, NA; Mathie, RT; Serracino-Inglott, F; Virlos, IT; Williamson, RC | 1 |
RUSZKOWSKI, M; WYSOCKI, K | 1 |
MAEDA, K; MATSUNAKA, M; NISHIMURA, N; OKAMOTO, H; TOSHINA, H; YASUI, M | 1 |
DAVID, G; FABER, V; SOLYOM, A | 1 |
AKISAWA, J | 1 |
GJESSING, LR; HALVORSEN, S | 1 |
CHODOS, RB; RUEGAMER, WR; SILVERMAN, FR | 1 |
DAVID, G; GYARMATI, L; KELETI, B; PINTER, Z | 1 |
Hinson, JA; James, LP; Mayeux, PR | 1 |
FELIX, K; LEONHARDI, G; von GLASENAPP, I | 1 |
Berg, T; Halangk, J; Kage, A; Landt, O; Luck, W; Mueller, T; Neuhaus, P; Nickel, R; Puhl, G; Wiedenmann, B; Witt, H | 1 |
Koreeda, C; Mizuno, T; Okazaki, K; Seki, T | 1 |
Brock, RW; Dorman, RB; MacMillan-Crow, LA; Saba, H; Shoemaker, JL; Wunder, C | 1 |
McKiernan, PJ | 1 |
Charuel, C; Clayton, TA; Everett, JR; Hanton, G; Le Net, JL; Lindon, JC; Nicholson, JK; Provost, JP; Tang, H; Yap, IK | 1 |
Day, BJ; Khoo, NH; Parks, DA; Wu, TJ; Zhou, F | 1 |
Cederbaum, AI; Dey, A | 1 |
Fukuyama, T; Ito, N; Sato, M; Terawaki, A; Yamanouchi, M | 1 |
Conn, HO; Levine, RJ | 1 |
Boyle, AJ; Keech, MK; McCann, DS; Mitchell, JG | 1 |
Hirose, S; Nagasue, N; Ogawa, Y; Sasaki, Y; Yukaya, H | 1 |
Haddow, JE; Hostetter, MK; Knight, GJ; Levy, HL; Winter, HS | 1 |
Higashi, T; Nagashima, H; Watanabe, A | 1 |
Mowat, AP | 2 |
Grenier, A; Meister, A; New, MI; Rifkind, AB; Sassa, S; Starkman, H; Steinherz, PG; Stoner, E; Wellner, D; Wellner, VP | 1 |
Katz, AJ | 1 |
Gagné, R | 1 |
Chang, TM; Shu, CD | 2 |
Rabinowitz, JG | 1 |
Davis, M; O'Keefe, SJ; Williams, R | 1 |
Gribble, DH; Gulick, BA; Liu, IK; Qualls, CW; Rogers, QR | 1 |
Antonini, L; Bellusci, R; Bernardi, M; Cavallari, A; Dioguardi, FS; Gasbarrini, G; Mazziotti, A; Papa, V; Possati, L; Tacconi, C | 1 |
Abraham, R; Davis, M; El-Zayadi, A; Marshall, W; O'Keefe, SJ; Williams, R | 1 |
Goldberg, A; McColl, KE | 1 |
Gerok, W; Heberer, M; Maier, KP; Talke, H | 1 |
al-Dhalimy, M; Finegold, M; Grompe, M; Kennaway, NG; Lindstedt, S; Ou, CN; Papaconstantinou, J; Torres-Ramos, CA | 1 |
Perlmutter, DH; Teckman, J | 1 |
Beermann, F; Grund, C; Kelsey, G; Ruppert, S; Schütz, G; Tanguay, RM | 1 |
al-Dhalimy, M; Burlingame, T; Finegold, M; Grompe, M; Kennaway, NG; Ou, CN; Soriano, P | 1 |
Owada, M | 1 |
Kane, PA; Karani, JB; Meili-Vergani, G; Williams, R | 1 |
Möhler, M; Stremmel, W; Wagner, V | 1 |
Endo, F | 1 |
Adachi, Y; Fujita, N; Gabazza, EC; Ikoma, J; Kaito, M; Kawamura-Yasui, N; Nakagawa, N; Watanabe, S | 1 |
Heikinheimo, M; Näntö-Salonen, K; Pitkänen, S; Salo, MK; Vettenranta, K | 1 |
Engelke, U; Lehnert, W; Stögmann, W; van den Berg, GB; Wevers, RA | 1 |
Marx, JJ; Swinkels, DW | 1 |
Ashur, Y; Berry, EM; Ilan, Y; Sasson, O; Sobol, T | 1 |
Hayashi, H; Ikeda, R; Imaizumi, Y; Kawanaka, M; Sanae, F; Shiono, Y; Takikawa, T; Wakusawa, S; Yamada, G; Yano, M; Yoshioka, K | 1 |
Fischer, JF | 1 |
Alvarez-Prechous, A; Díaz-Cardama, A; Lema, M; Noya, M | 1 |
Hanafusa, E; Harada, H; Ikubo, I; Kimura, I; Shundo, T; Takeda, M; Yabe, H | 1 |
Fisher, JE; Hodgman, J; James, JH; Rosen, HM; Soeters, PB | 1 |
Milsom, JP; Morgan, MY; Sherlock, S | 1 |
Bakker, HD; van Sprang, FJ; Wadman, SK | 1 |
Kanno, T; Murata, K; Muto, Y; Ohkubo, A; Sugiyama, M; Ueno, Y | 1 |
Kato, T; Moriwaki, U; Murakami, N; Muto, Y; Nakamura, T; Saito, K | 1 |
Horwich, AL | 1 |
Ascher, NL; Bloomer, JR; Freese, DK; Payne, WD; Rank, JM; Schwarzenberg, SJ; Sharp, HL; Tuchman, M | 1 |
Dicks-Mireaux, C; Leonard, JV; Macvicar, D; Wight, DG | 1 |
Iwamura, K; Noguchi, K; Ogawa, R; Ohtsuka, M; Watanabe, Y | 1 |
Kato, T; Mori, M; Moriwaki, H; Murakami, N; Muto, Y; Nakamura, T; Saito, K; Sugihara, J; Tomita, E; Yoshida, T | 1 |
Sassa, S | 1 |
Azuma, Y; Kanno, T; Kuwabara, Y; Maekawa, M; Nakajima, T; Taniguchi, K | 1 |
Bergan, A; Flatmark, A; Gjone, E; Halvorsen, S; Jellum, E; Kvittingen, EA; Schrumpf, E; Stokke, O; Sødal, G | 1 |
Bistrian, BR; Blackburn, GL; Crosby, L; Jenkins, RL; Lakshman, K; Shanbhogue, RL; Swenson, S; Wagner, D | 1 |
Mowat, A | 1 |
Endo, R; Ishii, M; Satoh, G; Satoh, R; Ueno, Y | 1 |
Dunlop, EH; Flax, H; Gazzard, BG; Langley, PG; Mellon, PJ; Murray-Lyon, IM; Portmann, B; Record, CO; Ward, MB; Weston, MJ; Williams, R | 1 |
Bona, C; Bonciu, C; Petrovici, M | 1 |
Gaull, GE; Rassin, DK; Sturman, JA | 1 |
Scriver, CR | 1 |
Gillich, KH; Krüskemper, HL; Ruge, W; Zielske, F | 1 |
Buffe, D; Rimbaut, C | 2 |
Odievre, M | 1 |
Kondrat'ev, VG; Kontsevaia, NG; Koval'skiĭ, GS; Kureeva, RIa; Shapiro, SE | 1 |
Tronnier, H | 1 |
Goldman, M; Griffin, AC | 1 |
Davidson, M; Silverberg, M | 1 |
Farriaux, JP; Fontaine, G | 1 |
Ruge, W | 1 |
Atkins, RJ; Holston, JL; Hosty, TS; Levy, HL; Patton, TH; Tomlin, GA | 1 |
Collombel, C; Cotte, J; David, M; Dutruge, J; Jeune, M; Michel, M | 1 |
Lowman, JT; Ulstrom, RA; Walker, WA | 1 |
Abdel Kader, MM; Abdel Wahab, F; Ata, AA; Emara, SH; Soliman, L | 1 |
Banicević, B; Glicić, L; Kangrga, R; Pastrakuljić, N; Perisić, V | 1 |
Woolf, LI | 1 |
15 review(s) available for tyrosine and Liver Dysfunction
Article | Year |
---|---|
Emerging roles of tyrosine kinases in hepatic inflammatory diseases and therapeutic opportunities.
Topics: Fibrosis; Humans; Liver Diseases; Protein-Tyrosine Kinases; Tyrosine | 2023 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Tyrosinemia and Liver Transplantation: Experience at CHU Sainte-Justine.
Topics: Animals; Canada; Humans; Liver Diseases; Liver Transplantation; Tyrosine; Tyrosinemias | 2017 |
Hereditary Tyrosinemia Type 1 in Turkey.
Topics: Cyclohexanones; Humans; Hydrolases; Liver; Liver Diseases; Nitrobenzoates; Turkey; Tyrosine; Tyrosinemias | 2017 |
Inborn Errors of Metabolism with Hepatopathy: Metabolism Defects of Galactose, Fructose, and Tyrosine.
Topics: Fructose; Galactose; Humans; Infant, Newborn; Liver; Liver Diseases; Metabolism, Inborn Errors; Tyrosine | 2018 |
Acetaminophen-induced hepatotoxicity.
Topics: Acetaminophen; Acetylcysteine; Analgesics, Non-Narcotic; Antidotes; Chemical and Drug Induced Liver Injury; Cytokines; Humans; Kupffer Cells; Liver Diseases; Mitochondria, Liver; Oxidative Stress; Tyrosine | 2003 |
Hepatic Disorders.
Topics: Adolescent; Adult; alpha 1-Antitrypsin Deficiency; Amino Acid Metabolism, Inborn Errors; Ammonia; Child; Child, Preschool; Cystic Fibrosis; Female; Fructose Intolerance; Fructose-1,6-Diphosphatase Deficiency; Galactosemias; Glycogen Storage Disease; Humans; Infant; Infant, Newborn; Liver Diseases; Male; Polycystic Kidney Diseases; Porphyrias; Tyrosine; Urea | 1982 |
Conceptual advances in the pathogenesis and treatment of childhood metabolic liver disease.
Topics: alpha 1-Antitrypsin Deficiency; Child; Gaucher Disease; Hepatolenticular Degeneration; Humans; Liver Diseases; Metabolism, Inborn Errors; Tyrosine | 1995 |
[Inborn errors of amino acid metabolism].
Topics: Amino Acid Metabolism, Inborn Errors; Humans; Infant, Newborn; Liver; Liver Diseases; Tyrosine | 1995 |
[Hereditary liver diseases. Recent molecular genetic aspects].
Topics: alpha 1-Antitrypsin; Animals; Bilirubin; Cholestasis, Intrahepatic; Cystic Fibrosis; Disease Models, Animal; Genetic Therapy; Hepatolenticular Degeneration; Humans; Jaundice, Chronic Idiopathic; Liver Diseases; Metabolism, Inborn Errors; Molecular Biology; Tyrosine | 1998 |
[Other abnormalities of tyrosine metabolism].
Topics: 4-Hydroxyphenylpyruvate Dioxygenase; Amino Acid Metabolism, Inborn Errors; Ascorbic Acid Deficiency; Humans; Infant, Newborn; Intellectual Disability; Liver Diseases; Tyrosine | 1998 |
[Diagnosis and treatment of primary hemochromatosis].
Topics: Cysteine; Female; Ferritins; Genetic Testing; Hemochromatosis; Homozygote; Humans; Liver Diseases; Liver Function Tests; Male; Mutation; Phlebotomy; Transferrin; Tyrosine | 1999 |
[Amino acid disturbances in liver failure].
Topics: Amino Acids; Humans; Infusions, Parenteral; Liver Diseases; Muscles; Octopamine; Tryptophan; Tyrosine | 1977 |
[Alpha fetoproteins].
Topics: alpha-Fetoproteins; Amino Acid Metabolism, Inborn Errors; Anencephaly; Ataxia Telangiectasia; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Chemical and Drug Induced Liver Injury; Contraceptives, Oral; Female; Fetal Death; Fetal Proteins; Hepatitis Viruses; Humans; Infant, Newborn; Jaundice, Neonatal; Liver; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Pregnancy; Pregnancy Complications; Prenatal Diagnosis; Spinal Dysraphism; Teratoma; Tyrosine | 1975 |
Inherited hepatic enzyme defects as candidates for liver-directed gene therapy.
Topics: Animals; DNA; Female; Genes, Viral; Genetic Therapy; Humans; Hydrolases; Liver Diseases; Liver Transplantation; Male; Mice; Ornithine Carbamoyltransferase; Ornithine Carbamoyltransferase Deficiency Disease; Prognosis; Tyrosine | 1991 |
3 trial(s) available for tyrosine and Liver Dysfunction
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction.
Topics: Adult; Antioxidants; Humans; Liver; Liver Diseases; Male; Microbiota; MicroRNAs; Phenylalanine; Tyrosine; Ursodeoxycholic Acid; Vitamin E; Young Adult | 2018 |
A balanced 5:1 carbohydrate:protein diet: a new method for supplementing protein to patients with chronic liver disease.
Topics: Adult; Amino Acids; Amino Acids, Branched-Chain; Behavior; Blood Glucose; Chronic Disease; Dietary Carbohydrates; Dietary Proteins; Female; Humans; Insulin; Liver Diseases; Male; Middle Aged; Tryptophan; Tyrosine | 2000 |
94 other study(ies) available for tyrosine and Liver Dysfunction
Article | Year |
---|---|
Easy clinical predictor for low BCAA to tyrosine ratio in chronic liver disease patients with hepatocellular carcinoma: Usefulness of ALBI score as nutritional prognostic marker.
Topics: Aged; Amino Acids, Branched-Chain; Bilirubin; Biomarkers; Carcinoma, Hepatocellular; Chronic Disease; Epidemiologic Methods; Female; Humans; Liver Diseases; Liver Neoplasms; Male; Nutritional Status; Prognosis; Protein-Energy Malnutrition; Serum Albumin; Tyrosine | 2021 |
The profiling of plasma free amino acids and the relationship between serum albumin and plasma-branched chain amino acids in chronic liver disease: a single-center retrospective study.
Topics: Adult; Aged; Amino Acids, Branched-Chain; Chronic Disease; Disease Progression; Female; Hepatitis C, Chronic; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Retrospective Studies; Serum Albumin; Severity of Illness Index; Tyrosine | 2018 |
Glycyrrhizin represses total parenteral nutrition-associated acute liver injury in rats by suppressing endoplasmic reticulum stress.
Topics: Animals; Apoptosis; Bilirubin; Caspase 3; Cytokines; Endoplasmic Reticulum Stress; Glycyrrhizic Acid; Immunohistochemistry; Inflammation; Inflammation Mediators; JNK Mitogen-Activated Protein Kinases; Liver; Liver Diseases; Male; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Parenteral Nutrition, Total; Phosphorylation; Rats, Sprague-Dawley; Reactive Nitrogen Species; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Transcription Factor CHOP; Triglycerides; Tyrosine | 2013 |
Dietary fish oil reduces systemic inflammation and ameliorates sepsis-induced liver injury by up-regulating the peroxisome proliferator-activated receptor gamma-mediated pathway in septic mice.
Topics: Animals; Biomarkers; Fatty Acids, Omega-3; Fish Oils; Inflammation; Interleukin-10; Interleukin-6; Liver; Liver Diseases; Male; Mice; Mice, Inbred ICR; NF-kappa B; Nitric Oxide Synthase Type II; Peroxidase; PPAR gamma; Sepsis; Tumor Necrosis Factor-alpha; Tyrosine; Up-Regulation | 2014 |
Oxidative stress and antioxidant status in patients with autoimmune liver diseases.
Topics: Adult; Aged; Aldehydes; Antioxidants; Autoimmune Diseases; Carbon; Catalase; Disease Progression; Female; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Hepatitis, Autoimmune; Humans; Isoprostanes; Liver Diseases; Male; Middle Aged; Oxidative Stress; Peroxidase; Superoxide Dismutase; Tyrosine | 2015 |
Propargylglycine aggravates liver damage in LPS-treated rats: Possible relation of nitrosative stress with the inhibition of H2S formation.
Topics: Alkynes; Amidohydrolases; Animals; Arginine; Aspartate Aminotransferases; Chromatography, High Pressure Liquid; Cystathionine gamma-Lyase; Endotoxemia; Glutathione; Glycine; Hydrogen Sulfide; Lipopolysaccharides; Liver Diseases; Male; Peroxidase; Rats; Rats, Wistar; Stress, Physiological; Tyrosine | 2014 |
Selective inhibition of iNOS attenuates trauma-hemorrhage/resuscitation-induced hepatic injury.
Topics: Amidines; Animals; Benzylamines; Blood Pressure; Chemokines; Cytokines; Disease Models, Animal; Enzyme Inhibitors; Fluid Therapy; Glutathione Transferase; Hypoxia-Inducible Factor 1, alpha Subunit; Intercellular Adhesion Molecule-1; Isoenzymes; Liver; Liver Diseases; Male; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Peroxidase; Rats; Rats, Sprague-Dawley; Resuscitation; Shock, Hemorrhagic; Tyrosine; Wounds and Injuries | 2008 |
Effect of bicyclol on cisplatin-induced hepatotoxicity in the hepatocarcinoma 22 tumour-bearing mice.
Topics: Animals; Antineoplastic Agents; Biphenyl Compounds; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Chemical and Drug Induced Liver Injury; Cisplatin; Drug Interactions; Gene Expression Regulation; L-Lactate Dehydrogenase; Liver; Liver Diseases; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred ICR; Nitric Oxide Synthase Type II; Transaminases; Tyrosine | 2009 |
Reactive oxygen species mediate liver injury through parenchymal nuclear factor-kappaB inactivation in prolonged ischemia/reperfusion.
Topics: Animals; Apoptosis; Blotting, Western; Cell Nucleus; Glutathione; Hepatocytes; I-kappa B Proteins; Interleukin-1beta; Kupffer Cells; Lipid Peroxidation; Liver Diseases; Male; Mice; Mice, Inbred C57BL; NF-kappa B; NF-KappaB Inhibitor alpha; Oxidative Stress; Peroxidase; Phosphorylation; Protein Transport; Reactive Oxygen Species; Reperfusion Injury; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Superoxide Dismutase; Tumor Necrosis Factor-alpha; Tyrosine | 2009 |
Polyphenols of Camellia sinenesis decrease mortality, hepatic injury and generation of cytokines and reactive oxygen and nitrogen species after hemorrhage/resuscitation in rats.
Topics: Alanine Transaminase; Animals; Blood Transfusion; Camellia sinensis; Cytokines; Female; Flavonoids; Lipid Peroxidation; Liver; Liver Diseases; Nitric Oxide Synthase Type II; Phenols; Phytotherapy; Plant Extracts; Polyphenols; Rats; Rats, Sprague-Dawley; Reactive Nitrogen Species; Reactive Oxygen Species; Resuscitation; Shock, Hemorrhagic; Tyrosine | 2010 |
The blood protein tyrosine reaction in malaria, acute epidemic hepatitis, and certain other diseases.
Topics: Blood; Blood Proteins; Hepatitis; Hepatitis A; Humans; Infections; Jaundice; Liver Diseases; Malaria; Tyrosine | 1946 |
Enhanced intrahepatic inducible nitric oxide synthase expression and nitrotyrosine accumulation in primary biliary cirrhosis and autoimmune hepatitis.
Topics: Adult; Chronic Disease; Female; Hepatitis, Autoimmune; Humans; Liver; Liver Cirrhosis, Biliary; Liver Diseases; Male; Middle Aged; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Severity of Illness Index; Tyrosine | 2002 |
Differential nitric oxide synthase expression during hepatic ischemia-reperfusion.
Topics: Animals; Blotting, Western; Disease Models, Animal; Fluorescent Antibody Technique; Ischemia; Liver; Liver Diseases; Liver Function Tests; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rats; Rats, Wistar; Reperfusion Injury; Tyrosine | 2003 |
Investigations on the content of methionine, tryptophane and tyrosine in the serum protein of patients with diffuse parenchymatous hepatic damage.
Topics: Blood; Blood Proteins; Liver Diseases; Methionine; Tryptophan; Tyrosine | 1952 |
Phenylalanine and tyrosine in collagen diseases. Urinary excretion of general intermediary metabolites of tyrosine in patients with collagen disease and liver disease.
Topics: Collagen Diseases; Humans; Liver Diseases; Phenylalanine; Tyrosine | 1961 |
[Significance of the serum tyrosine level in the evaluation of chronic liver damage. Experimental studies].
Topics: Abdominal Injuries; Carbon Tetrachloride Poisoning; Liver Diseases; Tyrosine | 1963 |
[CLINICAL STUDIES ON THE INTERMEDIARY METABOLISM OF TYROSINE. 1. URINARY EXCRETION OF INTERMEDIARY METABOLITES OF TYROSINE IN HEALTHY INDIVIDUALS AND PATIENTS WITH LIVER DISORDERS].
Topics: Biomedical Research; Hepatitis; Hepatitis A; Humans; Lactates; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Phenylpyruvic Acids; Proteins; Tyrosine; Urine | 1964 |
STUDIES ON TYROSINOSIS: 1, EFFECT OF LOW-TYROSINE AND LOW-PHENYLALANINE DIET.
Topics: Acetates; Amino Acid Metabolism, Inborn Errors; Amino Acids; Child; Diet; Diet Therapy; Hepatomegaly; Humans; Kidney; Kidney Function Tests; Lactates; Liver Diseases; Liver Function Tests; Phenylalanine; Phenylpyruvic Acids; Phosphates; Renal Aminoacidurias; Rickets; Tyrosine; Urine | 1964 |
Effect of liver disease on diiodotyrosine metabolism.
Topics: Diiodotyrosine; Liver Diseases; Tyrosine | 1960 |
[Change in plasma tyrosine concentrations in liver diseases].
Topics: Humans; Liver Diseases; Tyrosine; Vascular Diseases | 1962 |
[On tyrosinosis].
Topics: Amino Acid Metabolism, Inborn Errors; Humans; Liver Diseases; Tyrosine | 1951 |
Keratin 8 Y54H and G62C mutations are not associated with liver disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Chronic Disease; Cytosine; Guanine; Hepatitis, Autoimmune; Hepatitis, Viral, Human; Histidine; Humans; Keratin-8; Keratins; Liver Cirrhosis; Liver Diseases; Middle Aged; Mutation, Missense; Tyrosine | 2004 |
[Branched-chain amino acids and tyrosine moler ratio (BTR)].
Topics: Amino Acids, Branched-Chain; Humans; Liver Diseases; Tyrosine | 2004 |
NAD(P)H oxidase contributes to the progression of remote hepatic parenchymal injury and endothelial dysfunction, but not microvascular perfusion deficits.
Topics: Animals; Disease Progression; Endothelium; Liver; Liver Diseases; Male; Mice; Mice, Inbred C57BL; Microcirculation; Models, Biological; NADPH Oxidases; Neutrophils; Oxidative Stress; Peroxidase; Reperfusion Injury; Tyrosine; Xanthine Oxidase | 2006 |
Nitisinone in the treatment of hereditary tyrosinaemia type 1.
Topics: Carcinoma, Hepatocellular; Cyclohexanones; Enzyme Inhibitors; Humans; Kidney Diseases; Liver Diseases; Liver Failure; Liver Neoplasms; Liver Transplantation; Monitoring, Physiologic; Nitrobenzoates; Tyrosine; Tyrosinemias | 2006 |
An integrated metabonomic approach to describe temporal metabolic disregulation induced in the rat by the model hepatotoxin allyl formate.
Topics: Animals; Blood Chemical Analysis; Chemical and Drug Induced Liver Injury; Creatine; Formic Acid Esters; Glucose; Lipids; Liver; Liver Diseases; Liver Glycogen; Magnetic Resonance Spectroscopy; Rats; Taurine; Tyrosine | 2006 |
Decreased hepatic ischemia-reperfusion injury by manganese-porphyrin complexes.
Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Ischemia; L-Lactate Dehydrogenase; Lipid Peroxidation; Liver; Liver Diseases; Male; Metalloporphyrins; Mice; Mice, Inbred C57BL; Nitrosation; Reactive Oxygen Species; Reperfusion Injury; Thiobarbituric Acid Reactive Substances; Tyrosine | 2007 |
Induction of cytochrome P450 2E1 [corrected] promotes liver injury in ob/ob mice.
Topics: Acetone; Animals; Apoptosis; Caspase 3; Catalysis; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP2E1; DNA Adducts; DNA Fragmentation; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Lipid Peroxidation; Liver; Liver Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Nitric Oxide Synthase Type II; Obesity; Proteins; Pyrazoles; RNA, Messenger; Solvents; Tumor Necrosis Factor-alpha; Tyrosine | 2007 |
Phenylalanine hydroxylase activity in isolated, perfused liver of rats bearing rhodamine sarcoma, hepatoma, and nodular hyperplasia.
Topics: Animals; Carcinoma 256, Walker; Hyperplasia; In Vitro Techniques; Liver; Liver Diseases; Liver Regeneration; Male; Oxidoreductases; Perfusion; Phenylalanine; Rats; Sarcoma, Experimental; Tryptophan; Tyrosine | 1967 |
Tyrosine metabolism in patients with liver disease.
Topics: Adult; Alkaline Phosphatase; Ammonia; Biliary Tract Diseases; Bilirubin; Glutamate Dehydrogenase; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Phenylalanine; Portacaval Shunt, Surgical; Serum Albumin; Sulfobromophthalein; Tyrosine | 1967 |
Tyrosine metabolism in connective tissue disease. P-hydroxyphenylpyruvic acid excretion.
Topics: Arthritis, Rheumatoid; Collagen Diseases; Connective Tissue; Glucuronates; Humans; Liver Diseases; Lupus Erythematosus, Systemic; Phenylpyruvic Acids; Scleroderma, Systemic; Spectrum Analysis; Tyrosine | 1967 |
Infusion of branched chain amino acids after partial hepatectomy in man.
Topics: Amino Acids; Amino Acids, Branched-Chain; Ammonia; Carcinoma, Hepatocellular; Female; Hepatectomy; Humans; Infusions, Parenteral; Kinetics; Liver Diseases; Liver Neoplasms; Male; Methionine; Middle Aged; Phenylalanine; Tyrosine | 1984 |
False neurotransmitters and hepatic failure.
Topics: Hemodynamics; Humans; Liver Diseases; Octopamine; Phenylalanine; Tyrosine | 1982 |
Evidence for liver disease preceding amino acid abnormalities in hereditary tyrosinemia.
Topics: alpha-Fetoproteins; Amino Acid Metabolism, Inborn Errors; Female; Fetal Blood; Humans; Infant; Infant, Newborn; Liver Diseases; Male; Methionine; Tyrosine | 1983 |
A rapid method for monitoring serum neutral amino acid concentrations in severe liver disease.
Topics: Amino Acids; Amino Acids, Essential; Carcinoma, Hepatocellular; Chromatography, Liquid; Hepatic Encephalopathy; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Monitoring, Physiologic; Prognosis; Tyrosine | 1981 |
Biochemical studies of a patient with hereditary hepatorenal tyrosinemia: evidence of glutathione deficiency.
Topics: Erythrocytes; Fanconi Syndrome; Female; Glutathione; Heme; Humans; Infant; Liver; Liver Diseases; Mass Spectrometry; Mixed Function Oxygenases; Phosphates; Pyrroles; Rickets; Syndrome; Tyrosine | 1984 |
Diagnostic procedures in the evaluation of hepatic diseases. Metabolic errors.
Topics: Adolescent; Adult; alpha 1-Antitrypsin Deficiency; Child; Fructose Intolerance; Galactosemias; Hepatolenticular Degeneration; Humans; Infant, Newborn; Liver Diseases; Metabolism, Inborn Errors; Phenotype; Tyrosine | 1983 |
Liver disease in hereditary tyrosinemia.
Topics: Amino Acid Metabolism, Inborn Errors; Humans; Liver Diseases; Tyrosine | 1983 |
Tyrosinase immobilized within artificial cells for detoxification in liver failure: I. preparation and in vitro studies.
Topics: Artificial Organs; Blood; Catechol Oxidase; Liver; Liver Diseases; Monophenol Monooxygenase; Time Factors; Tyrosine; Ultrafiltration | 1980 |
Tyrosinase immobilized within artificial cells for detoxification in liver failure: II. In vivo studies in fulminant hepatic failure rats.
Topics: Animals; Catechol Oxidase; Chemical and Drug Induced Liver Injury; Enzymes, Immobilized; Galactosamine; Hemoperfusion; Inactivation, Metabolic; Liver Diseases; Male; Monophenol Monooxygenase; Rats; Rats, Inbred Strains; Tyrosine | 1981 |
Abnormalities of the liver and other organs.
Topics: Abnormalities, Multiple; alpha 1-Antitrypsin Deficiency; Amino Acid Metabolism, Inborn Errors; Colitis; Colon; Cystinosis; Heart Failure; Hemochromatosis; Hepatolenticular Degeneration; Humans; Liver; Liver Diseases; Necrosis; Radiography; Sclerosis; Tyrosine | 1980 |
Evidence for the vivo compartmentation of amino acids between blood cells and plasma in man with liver disease during constant infusion of L (U-14C) tyrosine.
Topics: Amino Acids; Erythrocytes; Humans; Liver Diseases; Middle Aged; Plasma; Tyrosine | 1982 |
Effect of pyrrolizidine alkaloid-induced hepatic disease on plasma amino acid patterns in the horse.
Topics: 2-Aminoadipic Acid; Amino Acids; Ammonia; Animals; Horse Diseases; Horses; Isoleucine; Leucine; Liver Diseases; Male; Phenylalanine; Plant Poisoning; Plants, Toxic; Pyrrolizidine Alkaloids; Senecio; Tyrosine; Valine | 1980 |
Plasma amino acid patterns in experimental acute hepatic failure: comparison between hepatectomy and liver devascularization in pigs.
Topics: Amino Acids; Animals; Female; Hepatectomy; Ischemia; Liver; Liver Diseases; Methionine; Phenylalanine; Swine; Tryptophan; Tyrosine | 1981 |
Increased plasma tyrosine concentrations in patients with cirrhosis and fulminant hepatic failure associated with increased plasma tyrosine flux and reduced hepatic oxidation capacity.
Topics: Amino Acids; Humans; Kinetics; Liver; Liver Cirrhosis; Liver Diseases; Middle Aged; Oxidation-Reduction; Proteins; Tyrosine | 1981 |
Abnormal porphyrin metabolism in diseases other than prophyria.
Topics: Alcohol Drinking; Amino Acid Metabolism, Inborn Errors; Anemia, Hemolytic; Anemia, Hypochromic; Anemia, Megaloblastic; Anemia, Sickle Cell; Anemia, Sideroblastic; Humans; Lead Poisoning; Leukemia; Liver Diseases; Malabsorption Syndromes; Mental Disorders; Polycythemia; Porphyrins; Time Factors; Tyrosine | 1980 |
Metabolism of phenylalanine in liver diseases.
Topics: DNA; Humans; Kinetics; Liver Diseases; Phenylalanine; Phenylalanine Hydroxylase; Tyrosine | 1980 |
Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I.
Topics: alpha-Fetoproteins; Amino Acid Metabolism, Inborn Errors; Amino Acids; Animals; Cyclohexanones; Disease Models, Animal; Enzyme Inhibitors; Female; Heptanoates; Humans; Hydrolases; Liver; Liver Diseases; Liver Neoplasms; Male; Mice; Mice, Inbred C57BL; Nitrobenzoates; Pancreas; RNA, Messenger; Tyrosine | 1995 |
Image interpretation session. Tyrosinemia with hepatic and renal involvement and possible associated hepatocellular carcinoma.
Topics: Amino Acid Metabolism, Inborn Errors; Carcinoma, Hepatocellular; Female; Humans; Infant; Kidney Diseases; Liver; Liver Diseases; Liver Neoplasms; Tyrosine | 1995 |
Rescue of mice homozygous for lethal albino deletions: implications for an animal model for the human liver disease tyrosinemia type 1.
Topics: Albinism; Animals; Disease Models, Animal; Gene Deletion; Gene Expression; Homozygote; Humans; Hydrolases; Hypoglycemia; Liver; Liver Diseases; Mice; Mice, Transgenic; Phenotype; Tyrosine | 1993 |
Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice.
Topics: Albinism; Animals; Animals, Newborn; Base Sequence; Cells, Cultured; Endoplasmic Reticulum; Gene Deletion; Gene Expression; Hydrolases; Liver Diseases; Mice; Microscopy, Electron; Molecular Sequence Data; Phenotype; RNA, Messenger; Tyrosine | 1993 |
Pseudotumours of hepatic imaging.
Topics: Adolescent; Adult; Aged; alpha 1-Antitrypsin Deficiency; Amino Acid Metabolism, Inborn Errors; Diagnosis, Differential; Gaucher Disease; Humans; Infant; Liver Diseases; Liver Failure; Liver Transplantation; Tomography, X-Ray Computed; Tyrosine | 1996 |
Evaluating response to nutritional therapy using the branched-chain amino acid/tyrosine ratio in patients with chronic liver disease.
Topics: Amino Acids, Branched-Chain; Bilirubin; Cholinesterases; Chronic Disease; Dietary Proteins; Female; Hepatitis, Chronic; Humans; Hyaluronic Acid; Kinetics; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Platelet Count; Serum Albumin; Tyrosine | 1999 |
Serum type III procollagen in children with type I hereditary tyrosinemia.
Topics: Adolescent; Amino Acid Metabolism, Inborn Errors; Biomarkers; Child; Child, Preschool; Disease Progression; Female; Humans; Infant; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Male; Procollagen; Tyrosine | 1999 |
Long-term follow up of a new case of hawkinsinuria.
Topics: 4-Hydroxyphenylpyruvate Dioxygenase; Acidosis, Renal Tubular; Amino Acid Metabolism, Inborn Errors; Amino Acids, Sulfur; Cyclohexenes; Diagnosis, Differential; Follow-Up Studies; Fructose Intolerance; Growth Disorders; Humans; Infant; Liver Diseases; Male; Tyrosine | 1999 |
C282Y and H63D mutations in the HFE gene have no effect on iron overload disorders in Japan.
Topics: Adult; Asian People; Aspartic Acid; Cysteine; Female; Hemochromatosis; Hemochromatosis Protein; Hepatitis C, Chronic; Histidine; Histocompatibility Antigens Class I; HLA Antigens; Humans; Iron Overload; Japan; Liver Diseases; Male; Membrane Proteins; Middle Aged; Point Mutation; Polymerase Chain Reaction; Tyrosine | 2001 |
[Exocrine pancreatic function test by a synthetic peptide in pancreatic and hepatobiliary diseases: in comparison with pancreozymin secretin test (author's transl)].
Topics: 4-Aminobenzoic Acid; Aminobenzoates; Biliary Tract Diseases; Cholecystokinin; Evaluation Studies as Topic; Humans; Liver Diseases; Pancreatic Diseases; Pancreatic Function Tests; para-Aminobenzoates; Secretin; Tyrosine | 1979 |
Influences of exogenous intake and nitrogen balance on plasma and brain aromatic amino acid concentrations.
Topics: Amino Acids; Animals; Disease Models, Animal; Female; Liver Diseases; Nitrogen; Octopamine; Parenteral Nutrition; Phenylalanine; Portacaval Shunt, Surgical; Rats; Tryptophan; Tyrosine | 1978 |
Plasma ratio of valine, leucine and isoleucine to phenylalanine and tyrosine in liver disease.
Topics: Adult; Amino Acids; Female; Hepatic Encephalopathy; Humans; Isoleucine; Leucine; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Phenylalanine; Tyrosine; Valine | 1978 |
[Tyrosinosis].
Topics: Acute Disease; Amino Acid Metabolism, Inborn Errors; Ascorbic Acid; Chronic Disease; Female; Growth Disorders; Hematuria; Humans; Infant, Newborn; Liver; Liver Diseases; Male; Methionine; Pregnancy; Tyrosine | 1976 |
New treatment for tyrosinaemia.
Topics: 4-Hydroxyphenylpyruvate Dioxygenase; Amino Acid Metabolism, Inborn Errors; Cyclohexanones; Humans; Infant; Kidney Diseases; Liver Diseases; Nitrobenzoates; Tyrosine | 1992 |
[The clinical usefulness of the molar ratio of branched-chain amino acids to tyrosine (BTR) in discriminating stage of chronic liver diseases].
Topics: Adult; Amino Acids, Branched-Chain; Chromatography, High Pressure Liquid; Chronic Disease; Diagnosis, Differential; Female; Humans; Liver Diseases; Male; Middle Aged; Tyrosine | 1992 |
Changes in brain monoamine metabolism in rats with acute ischemic hepatic failure under artificial cardiopulmonary management.
Topics: Animals; Brain; Dopamine; Hepatic Encephalopathy; Ischemia; Liver; Liver Diseases; Male; Norepinephrine; Phenylalanine; Rats; Rats, Inbred Strains; Respiration, Artificial; Serotonin; Tyrosine | 1992 |
Early liver transplantation is indicated for tyrosinemia type I.
Topics: Amino Acid Metabolism, Inborn Errors; Child, Preschool; Female; Humans; Infant; Liver Diseases; Liver Transplantation; Male; Time Factors; Tyrosine | 1991 |
Hepatic imaging with computed tomography of chronic tyrosinaemia type 1.
Topics: Amino Acid Metabolism, Inborn Errors; Child; Child, Preschool; Humans; Infant; Infant, Newborn; Liver; Liver Diseases; Liver Transplantation; Tomography, X-Ray Computed; Tyrosine | 1990 |
Anti-O-phosphotyrosine antibodies in human sera.
Topics: Adolescent; Adult; Aged; Antibodies; Antibody Affinity; Child; Child, Preschool; Collagen Diseases; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Infant; Infant, Newborn; Liver Diseases; Lung Diseases; Male; Middle Aged; Neoplasms; Nervous System Diseases; Phosphotyrosine; Tyrosine | 1985 |
[Enzymatic determination of a molar ratio of free branched-chain amino acids to tyrosine (BTR) and its clinical significance in plasma of patients with various liver diseases].
Topics: Amino Acids, Branched-Chain; Enzymes; Humans; Liver Diseases; Osmolar Concentration; Tyrosine | 1989 |
[Significance of delta-aminolevulinic acid analysis in clinical tests].
Topics: Amino Acid Metabolism, Inborn Errors; Aminolevulinic Acid; Chromatography, Gas; Chromatography, High Pressure Liquid; Colorimetry; Humans; Lead Poisoning; Levulinic Acids; Liver Diseases; Porphyrias; Reference Values; Tyrosine | 1989 |
Determination of branched-chain amino acids and tyrosine in serum of patients with various hepatic diseases, and its clinical usefulness.
Topics: Adult; Amino Acids, Branched-Chain; Humans; Liver Diseases; Middle Aged; Monitoring, Physiologic; Prognosis; Tyrosine | 1989 |
Liver transplantation in a 23-year-old tyrosinaemia patient: effects on the renal tubular dysfunction.
Topics: Adult; Amino Acid Metabolism, Inborn Errors; Amino Acids; beta 2-Microglobulin; Female; Glycosuria; Heptanoates; Humans; Kidney Diseases; Kidney Tubules; Liver Diseases; Liver Transplantation; Phosphates; Tyrosine | 1986 |
Liver disorders in children: the indications for liver replacement in parenchymal and metabolic diseases.
Topics: Amino Acid Metabolism, Inborn Errors; Budd-Chiari Syndrome; Child; Cholangitis; Crigler-Najjar Syndrome; Hepatitis, Chronic; Hepatolenticular Degeneration; Humans; Infant; Liver Cirrhosis; Liver Diseases; Liver Transplantation; Porphyrias; Tyrosine | 1987 |
Whole body leucine, phenylalanine, and tyrosine kinetics in end-stage liver disease before and after hepatic transplantation.
Topics: Carbon Isotopes; Female; Humans; Kinetics; Leucine; Liver Diseases; Liver Transplantation; Male; Middle Aged; Phenylalanine; Tyrosine | 1987 |
The management of metabolic disorders of the liver.
Topics: alpha 1-Antitrypsin Deficiency; Child, Preschool; Fructose Intolerance; Galactosemias; Genetic Counseling; Glycogen Storage Disease; Hepatolenticular Degeneration; Humans; Hydrolases; Infant; Infant, Newborn; Liver Diseases; Metabolic Diseases; Phenotype; Prognosis; Tyrosine | 1985 |
[Estimation and clinical significance of serum tyrosine concentrations in patients with liver disease].
Topics: Amino Acids, Branched-Chain; Chronic Disease; Fluorometry; Humans; Liver Diseases; Male; Middle Aged; Tyrosine | 1985 |
Charcoal haemoperfusion in the treatment of fulminant hepatic failure.
Topics: Adolescent; Adult; Amino Acids; Autopsy; Biopsy, Needle; Blood; Blood Cell Count; Blood Coagulation; Blood Platelets; Blood Specimen Collection; Charcoal; Female; Halothane; Hepatic Encephalopathy; Humans; Liver; Liver Diseases; Liver Function Tests; Male; Methionine; Methods; Middle Aged; Perfusion; Phenylalanine; Tyrosine | 1974 |
[Chemical structure of hyalin in hyalinosis of the spleen and liver].
Topics: Animals; Arginine; Glycoproteins; Glycosaminoglycans; Guinea Pigs; Histocytochemistry; Hyalin; Liver Diseases; Lysine; Mice; Splenic Diseases; Staining and Labeling; Tyrosine | 1966 |
Significance of hypermethionaemia in acute tyrosinosis.
Topics: Acute Disease; Amino Acid Metabolism, Inborn Errors; Child, Preschool; Humans; Infant; Liver Diseases; Methionine; Phenotype; Tyrosine | 1968 |
Significance of hypermethionaemia in acute tyrosinosis.
Topics: Acute Disease; Amino Acid Metabolism, Inborn Errors; Humans; Infant, Newborn; Liver Diseases; Methionine; Phenotype; Tyrosine | 1968 |
[Serum tyrosine determination as a thyroid function test].
Topics: Alkaline Phosphatase; Diagnosis, Differential; Humans; Hyperthyroidism; Hypothyroidism; Kwashiorkor; Liver Diseases; Thyroid Function Tests; Thyroxine; Tritium; Tyrosine | 1968 |
[Alpha l-fetoprotein in liver diseases and metabolic disorders in children].
Topics: Adolescent; Carcinoma, Hepatocellular; Child; Child, Preschool; Female; Fetal Proteins; Hepatitis; Hepatitis A; Hepatomegaly; Humans; Immunodiffusion; Infant; Infant, Newborn; Infant, Premature, Diseases; Liver Diseases; Liver Neoplasms; Male; Metabolic Diseases; Neoplasm Metastasis; Radioimmunoassay; Tyrosine | 1973 |
[Alpha 1-fetoprotein in liver diseases and metabolic disorders in children].
Topics: Adolescent; Carcinoma, Hepatocellular; Child; Child, Preschool; Female; Fetal Proteins; Hepatitis; Hepatitis A; Hepatomegaly; Humans; Immunodiffusion; Infant; Infant, Newborn; Infant, Premature, Diseases; Liver Diseases; Liver Neoplasms; Male; Metabolic Diseases; Neoplasm Metastasis; Radioimmunoassay; Tyrosine | 1973 |
[Acute metabolic liver in infants. Remarks on a practical approach].
Topics: Amino Acid Metabolism, Inborn Errors; Carbohydrate Metabolism, Inborn Errors; Diet Therapy; Fructose; Galactosemias; Humans; Infant; Infant, Newborn; Liver; Liver Diseases; Tyrosine | 1973 |
[Aromatic compounds in certain infectious diseases].
Topics: Amino Acids; Erysipelas; Homogentisic Acid; Humans; Indican; Infections; Kynurenine; Liver Diseases; Nicotinic Acids; Phenylpyruvic Acids; Pneumonia; Tryptophan; Tyrosine; Xanthurenates | 1973 |
[Diagnosis and therapy of the secondary disease: dermatology].
Topics: Candidiasis; Diabetes Complications; Female; Herpes Zoster; Humans; Liver Diseases; Malabsorption Syndromes; Male; Parathyroid Diseases; Phenylalanine; Pigmentation Disorders; Skin Diseases; Skin Manifestations; Tryptophan; Tyrosine; Vitamin B 12 Deficiency | 1973 |
Transfer RNA patterns in livers of rats fed diets containing 3'-methyl-4-dimethylaminoazobenzene.
Topics: Amino Acids; Animals; Arginine; Carbon Isotopes; Cell Transformation, Neoplastic; Chemical and Drug Induced Liver Injury; Chromatography; Female; Histidine; Leucine; Liver Diseases; Lysine; Methionine; Methylation; p-Dimethylaminoazobenzene; Phenylalanine; Precancerous Conditions; Rats; RNA, Transfer; Serine; Threonine; Tritium; Tyrosine; Valine | 1970 |
Nutritional requirements of infants and children with liver disease.
Topics: Adolescent; Bile; Body Weight; Carbohydrate Metabolism, Inborn Errors; Child; Child, Preschool; Cystic Fibrosis; Female; Galactosemias; Glycogen; Hepatitis A; Hepatolenticular Degeneration; Humans; India; Infant; Infant Nutritional Physiological Phenomena; Liver Diseases; Male; Tyrosine | 1970 |
[Tyrosinosis or tyrosinemia?].
Topics: Female; Humans; Infant; Infant, Newborn; Liver Diseases; Metabolism, Inborn Errors; Tyrosine | 1972 |
[Metabolic disorders and encephalopathy. Studies on phenolic compounds in consciousness disorders following liver diseases].
Topics: Amino Acids; Blood-Brain Barrier; Brain Diseases; Cognition Disorders; Female; Hepatic Encephalopathy; Humans; Liver Diseases; Male; Metabolic Diseases; Middle Aged; Phenols; Tyrosine; Uremia | 1972 |
Tyrosinosis: a patient without liver or renal disease.
Topics: Amino Acid Metabolism, Inborn Errors; Child; Chromatography, Ion Exchange; Chromatography, Paper; Humans; Intellectual Disability; Kidney Diseases; Lactates; Liver; Liver Diseases; Male; Mixed Function Oxygenases; Phenylacetates; Phenylpyruvic Acids; Tyrosine | 1971 |
[Transient hypertyrosinemia secondary to hepatic involvement. 2 cases of different etiologies (galactosemia, hepatitis)].
Topics: Female; Galactosemias; Hepatitis; Humans; Infant; Infant, Newborn; Liver Diseases; Male; Methionine; Tyrosine | 1970 |
Albumin synthesis rates in patients with hypoproteinemia.
Topics: Adolescent; Amino Acid Metabolism, Inborn Errors; Anaphylaxis; Anorexia Nervosa; Bile Ducts; Child; Child, Preschool; Chromatography, Gel; Colitis, Ulcerative; Cystic Fibrosis; Female; Glomerulonephritis; Humans; Hypoproteinemia; Infant; Injections, Intravenous; Intellectual Disability; Kinetics; Liver; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Diseases; Male; Methionine; Nephrotic Syndrome; Psychomotor Disorders; Purpura; Radioisotopes; Selenium; Serum Albumin; Spectrophotometry; Tyrosine | 1971 |
Urinary amino acid patterns in simple and complicated bilharziasis.
Topics: Adolescent; Adult; Aged; Alanine; Amino Acids; Ascites; Chromatography, Paper; Cystinuria; Hepatomegaly; Humans; Liver Diseases; Male; Middle Aged; Schistosomiasis; Splenomegaly; Threonine; Tryptophan; Tyrosine | 1969 |
[Disorders of the tyrosine function in liver diseases].
Topics: Humans; Liver Diseases; Tyrosine | 1965 |
Tyrosinosis (inborn hepato-renal dysfunction).
Topics: Acute Kidney Injury; Adolescent; Child; Child, Preschool; Humans; Infant, Newborn; Infant, Newborn, Diseases; Liver Diseases; Metabolism, Inborn Errors; Tyrosine | 1966 |